insights_auto
Why is GIS up ३.५८%?
Dive Deeperchevron_right
GIS:FRA
गिलियड साइन्सेस
€ १३५.५६
arrow_upward
+३.५८%(+४.६८) 1D
अक्टोबर १२, १५:५६:४२ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
€ १३४.८०
High
€ १३५.५६
Low
€ १३४.८०
Mkt. cap
१.८७ खरब
Avg. vol.
३८६.००
Volume
१.१६ हजार
52-wk high
€ १३५.५६
52-wk low
€ ९७.७९
No. of employees
१७ हजार
Open
€ १३४.८०
High
€ १३५.५६
Low
€ १३४.८०
Mkt. cap
१.८७ खरब
Avg. vol.
३८६.००
Volume
१.१६ हजार
52-wk high
€ १३५.५६
52-wk low
€ ९७.७९
No. of employees
१७ हजार
News stories
From web sources and news partners
Yahoo Finance
·
५ घण्टा पहिले
Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says
Insider Monkey
·
६ घण्टा पहिले
Can Gilead (GILD) Stock Continue Rising in 2027?
Investing.com
·
८ घण्टा पहिले
BofA raises Gilead Sciences stock price target on growth outlook
ad-hoc-news.de
·
९ घण्टा पहिले
RBC raised target for Gilead Sciences stock to USD 126.00
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About गिलियड साइन्सेस
CEODaniel O'Day
Employees१७ हजार
Founded१९८७ जुन २२
HeadquartersFoster City, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitegilead.com